Clinical Study
Volumetric Modulated Arc Therapy of the Pelvic Lymph Nodes to the Aortic Bifurcation in Higher Risk Prostate Cancer: Early Toxicity Outcomes
Table 3
Patient and tumour characteristics: entire cohort (
).
| | Age (yrs) | Mean (range) | Distant metastases | (%) |
| | | 67 (49–81) | No | 107 (95%) | | | | Yes | 4 (4%) | | | | Unknown | 2 (2%) |
| | T stage | (%) | Gleason score | (%) |
| | T1-2a | 38 (34%) | 7 | 50 (44%) | | T2b | 8 (7%) | 8 | 18 (16%) | | T2c-4 | 60 (53%) | 9 | 42 (37%) | | Unknown | 7 (6%) | Unknown | 3 (3%) |
| | Nodal status | (%) | D’Amico Risk Group | (%) |
| | Negative | 74 (65%) | Intermediate | 46 (41%) | | Positive | 15 (13%) | High | 63 (56%) | | Unknown | 24 (21%) | Unknown | 4 (4%) |
|
|
